David Sidransky

Director, Head & Neck Cancer Research Division at Johns Hopkins University

David Sidransky

David Sidransky

Director, Head & Neck Cancer Research Division at Johns Hopkins University

Overview
Career Highlights

Israel Biotech Fund

RelSci Relationships

4541

Number of Boards

23

Birthday

1961

Age

58

Number of Awards

2

Relationships
RelSci Relationships are individuals David Sidransky likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Co-Director of Drug Development & Gastrointestinal Oncology at Johns Hopkins University

Relationship likelihood: Strong

Founder at Jounce Therapeutics, Inc.

Relationship likelihood: Strong

Executive Chairman at Rgenix, Inc.

Relationship likelihood: Strong

Neurosurgeon-in-Chief at Johns Hopkins University - School of Medicine

Relationship likelihood: Strong

Chief Executive Officer & Director at Champions Oncology, Inc.

Relationship likelihood: Strong

Director of Nursing at The Johns Hopkins Hospital, Inc.

Relationship likelihood: Strong

Associate Director, Initiative to Eliminate Cancer Disparities at Dana-Farber/Harvard Cancer Center

Relationship likelihood: Strong

Frances Watt Baker & Lenox D. Baker Junior Dean, Medical Faculty at Johns Hopkins University - School of Medicine

Relationship likelihood: Strong

Director, Division of Neuropathology at The Johns Hopkins Hospital, Inc.

Relationship likelihood: Strong

Vice Provost for Information Technology & Chief Information Officer at Johns Hopkins University

Relationship likelihood: Strong

Paths to David Sidransky
Potential Connections via
Relationship Science
You
David Sidransky
Director, Head & Neck Cancer Research Division at Johns Hopkins University
Education
BA

Brandeis University is an American private research university with a liberal arts focus. It is located in Waltham, Massachusetts, 9 miles (14 km) west of Boston. The university has an enrollment of approximately 3,600 undergraduate and 2,200 graduate students.[4] It was tied for 32nd among national universities in the United States in U.S. News & World Report 's 2014 rankings. Forbes listed Brandeis University as number 51 among all national universities and liberal arts colleges combined in 2013. Brandeis was founded in 1948 as a nonsectarian Jewish community-sponsored coeducational institution on the site of the former Middlesex University. The university is named for Louis Brandeis (1856–1941), the first Jewish Justice of the Supreme Court of the United States.

MD

Baylor College of Medicine is a health sciences university that creates knowledge and applies science and discoveries to further education, healthcare and community service locally and globally.

Career History
Member, Scientific Management Team
Current

20/20 GeneSystems, Inc. develops and commercializes proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is located in Rockville, MD.

Director, Head & Neck Cancer Research Division
Current

The Johns Hopkins University opened in 1876, with the inauguration of its first president, Daniel Coit Gilman. "What are we aiming at?" Gilman asked in his installation address. "The encouragement of research ... and the advancement of individual scholars, who by their excellence will advance the sciences they pursue, and the society where they dwell." The mission laid out by Gilman remains the university's mission today, summed up in a simple but powerful restatement of Gilman's own words: "Knowledge for the world." What Gilman created was a research university, dedicated to advancing both students' knowledge and the state of human knowledge through research and scholarship. Gilman believed that teaching and research are interdependent, that success in one depends on success in the other. A modern university, he believed, must do both well. The realization of Gilman's philosophy at Johns Hopkins, and at other institutions that later attracted Johns Hopkins-trained scholars, revolutionized higher education in America, leading to the research university system as it exists today. After more than 130 years, Johns Hopkins remains a world leader in both teaching and research. Eminent professors mentor top students in the arts and music, the humanities, the social and natural sciences, engineering, international studies, education, business and the health professions. Those same faculty members, and their research colleagues at the university's Applied Physics Laboratory, have each year since 1979 won Johns Hopkins more federal research and development funding than any other university. The university has nine academic divisions and campuses throughout the Baltimore-Washington area. The Krieger School of Arts and Sciences, the Whiting School of Engineering, the School of Education and the Carey Business School are based at the Homewood campus in northern Baltimore. The schools of Medicine, Public Health, and Nursing share a campus in east Baltimore with The Johns Hopkins Hospital. The Peabody Institute, a leading professional school of music, is located on Mount Vernon Place in downtown Baltimore. The Paul H. Nitze School of Advanced International Studies is located in Washington's Dupont Circle area. The Applied Physics Laboratory is a division of the university co-equal to the nine schools, but with a non-academic, research-based mission. APL, located between Baltimore and Washington, supports national security and also pursues space science, exploration of the Solar System and other civilian research and development. Johns Hopkins also has a campus near Rockville in Montgomery County, Md., and has academic facilities in Nanjing, China, and in Bologna, Italy. It maintains a network of continuing education facilities throughout the Baltimore-Washington region, including centers in downtown Baltimore, in downtown Washington and in Columbia. When considered in partnership with its sister institution, the Johns Hopkins Hospital and Health System, the university is Maryland's largest employer and contributes more than $10 billion a year to the state's economy

Co-Founder & General Partner
2014 - Current
Boards & Committees
Member, Scientific Advisory Board
2015 - Current
Lead Independent Director
2014 - Current

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on the development of the liver targeted stearoyl-coenzyme A desaturase-1 modulator Aramchol, novel, once-daily, oral therapy for the treatment of NASH for variable populations, as well as other liver associated disorders. The Aramchol is a synthetic conjugate of cholic acid, or a type of bile acid, and arachidic acid, or a type of saturated fatty acid, both of which, in their non-synthetic forms, are naturally occurring. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.

Chairman of the Board
2013 - Current

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Chair, Scientific Advisory Board
Current

SUPPORTING RESEARCH INTO THE TREATMENT AND CURE OF ADENOID CYSTIC CARCINOMA.

Member of the Recombinant DNA Advisory Committee
Current

NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe. NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. NIH leadership plays an active role in shaping the agency's research planning, activities, and outlook. The Office of the Director is the central office at NIH, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. The NIH Director, with a unique and critical perspective on the entire agency, is responsible for providing leadership to the Institutes and for constantly identifying needs and opportunities, especially for efforts that involve multiple Institutes. The NIH Director is assisted by the NIH Deputy Directors including the Principal Deputy Director, who shares in the overall direction of the agency's activities. NIH is responsive to Congressional legislation that adjusts NIH's programs to meet changing research needs. As a result of the NIH reauthorization process, NIH is able to respond strategically in an era when medical research requires constant innovation and increased interdisciplinary efforts. More than 80% of the NIH's budget goes to more than 300,000 research personnel at over 2,500 universities and research institutions. In addition, about 6,000 scientists work in NIH’s own Intramural Research laboratories, most of which are on the NIH main campus in Bethesda, Maryland. The main campus is also home to the NIH Clinical Center, the largest hospital in the world totally dedicated to clinical research. Successful biomedical research depends on the talent and dedication of the scientific workforce. NIH supports many innovative training programs and funding mechanisms that foster scientific creativity and exploration. The goal is to strengthen our nation’s research capacity, broaden our research base, and inspire a passion for science in current and future generations of researchers. NIH encourages and depends on public involvement in federally supported research and activities. NIH’s wide-ranging public efforts include outreach and education, nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in clinical research

Member, Medical Advisory Board
Current
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$500 - $999
2007

ACCELERATES THE CONQUEST OF CANCER BY FUNDING SCIENTIFIC RESEARCH, EDUCATION AND COMMUNICATION.

$100 - $249
2006

ACCELERATES THE CONQUEST OF CANCER BY FUNDING SCIENTIFIC RESEARCH, EDUCATION AND COMMUNICATION.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2004
American Association of Cancer Research - Richard and Hinda Rosenthal Memorial Award
American Board of Internal Medicine
Events
Speaker
Tiger 21 Group Meetings

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Sidransky. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Sidransky's profile does not indicate a business or promotional relationship of any kind between RelSci and David Sidransky.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/david-sidransky-3177440
  • https://relationshipscience.com/person/david-sidransky-3177440